199 related articles for article (PubMed ID: 17594526)
1. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.
Hofvind S; Geller B; Vacek PM; Thoresen S; Skaane P
Eur J Epidemiol; 2007; 22(7):447-55. PubMed ID: 17594526
[TBL] [Abstract][Full Text] [Related]
2. [The effectiveness of population-based breast cancer screening programme].
Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
[TBL] [Abstract][Full Text] [Related]
3. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
4. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
5. Comparing screening mammography for early breast cancer detection in Vermont and Norway.
Hofvind S; Vacek PM; Skelly J; Weaver DL; Geller BM
J Natl Cancer Inst; 2008 Aug; 100(15):1082-91. PubMed ID: 18664650
[TBL] [Abstract][Full Text] [Related]
6. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
7. Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?
Hofvind S; Wang H; Thoresen S
Acta Oncol; 2004; 43(5):467-73. PubMed ID: 15360051
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
Hoff SR; Klepp O; Hofvind S
J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer screening: characteristics and results of the Spanish programs].
Ascunce N; Delfrade J; Salas D; Zubizarreta R; Ederra M;
Med Clin (Barc); 2013 Jul; 141(1):13-23. PubMed ID: 22704275
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
11. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
Muratov S; Canelo-Aybar C; Tarride JE; Alonso-Coello P; Dimitrova N; Borisch B; Castells X; Duffy SW; Fitzpatrick P; Follmann M; Giordano L; Hofvind S; Lebeau A; Quinn C; Torresin A; Vialli C; Siesling S; Ponti A; Giorgi Rossi P; Schünemann H; Nyström L; Broeders M;
BMC Cancer; 2020 Aug; 20(1):795. PubMed ID: 32831048
[TBL] [Abstract][Full Text] [Related]
12. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
13. [Attendance in the Norwegian Breast Cancer Screening Programme].
Sebuødegård S; Sagstad S; Hofvind S
Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
[TBL] [Abstract][Full Text] [Related]
14. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
16. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
18. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.
Hofvind S; Bjurstam N; Sørum R; Bjørndal H; Thoresen S; Skaane P
J Med Screen; 2006; 13(4):192-6. PubMed ID: 17217608
[TBL] [Abstract][Full Text] [Related]
19. Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97.
Olivotto IA; Kan L; d'Yachkova Y; Burhenne LJ; Hayes M; Hislop TG; Worth AJ; Basco VE; King S
J Med Screen; 2000; 7(3):152-9. PubMed ID: 11126165
[TBL] [Abstract][Full Text] [Related]
20. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000.
Sarkeala T; Anttila A; Forsman H; Luostarinen T; Saarenmaa I; Hakama M
Eur J Cancer; 2004 Sep; 40(14):2116-25. PubMed ID: 15341987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
